Review



recombinant human rh gal 1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems recombinant human rh gal 1
    Recombinant Human Rh Gal 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human rh gal 1/product/R&D Systems
    Average 94 stars, based on 20 article reviews
    recombinant human rh gal 1 - by Bioz Stars, 2026-04
    94/100 stars

    Images



    Similar Products

    recombinant human lectin mgl fc  (Sino Biological)
    91
    Sino Biological recombinant human lectin mgl fc
    Recombinant Human Lectin Mgl Fc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human lectin mgl fc/product/Sino Biological
    Average 91 stars, based on 1 article reviews
    recombinant human lectin mgl fc - by Bioz Stars, 2026-04
    91/100 stars
    		  Buy from Supplier
    galectin 1 lgals1  (MedChemExpress)
    94
    MedChemExpress galectin 1 lgals1
    Gal-1 <t>=</t> <t>galectin-1;</t> GC = gastric cancer; NRP-1 = neuropilin-1; CCK-8 = Cell Counting Kit-8; BrdU = Bromodeoxyuridine. Statistical significance was assessed by t-test; * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001.
    Galectin 1 Lgals1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/galectin 1 lgals1/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    galectin 1 lgals1 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    galectin 7 concentrations  (Boster Bio)
    94
    Boster Bio galectin 7 concentrations
    Distributions of osteopontin <t>and</t> <t>galectin-7</t> in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Galectin 7 Concentrations, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/galectin 7 concentrations/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    galectin 7 concentrations - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    osteopontin  (Boster Bio)
    94
    Boster Bio osteopontin
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Osteopontin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteopontin/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    osteopontin - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    recombinant human rh gal 1  (R&D Systems)
    94
    R&D Systems recombinant human rh gal 1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Human Rh Gal 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human rh gal 1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human rh gal 1 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    recombinant human galectin-1  (Galectin Therapeutics)
    90
    Galectin Therapeutics recombinant human galectin-1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Human Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human galectin-1/product/Galectin Therapeutics
    Average 90 stars, based on 1 article reviews
    recombinant human galectin-1 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    recombinant human galectin 8  (Novus Biologicals)
    93
    Novus Biologicals recombinant human galectin 8
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Human Galectin 8, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human galectin 8/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    recombinant human galectin 8 - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    human recombinant (hr)galectin-1  (Galectin Therapeutics)
    90
    Galectin Therapeutics human recombinant (hr)galectin-1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Human Recombinant (Hr)Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human recombinant (hr)galectin-1/product/Galectin Therapeutics
    Average 90 stars, based on 1 article reviews
    human recombinant (hr)galectin-1 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    human recombinant (hr)-galectin-1  (Galectin Therapeutics)
    90
    Galectin Therapeutics human recombinant (hr)-galectin-1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Human Recombinant (Hr) Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human recombinant (hr)-galectin-1/product/Galectin Therapeutics
    Average 90 stars, based on 1 article reviews
    human recombinant (hr)-galectin-1 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; CCK-8 = Cell Counting Kit-8; BrdU = Bromodeoxyuridine. Statistical significance was assessed by t-test; * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001.

    Journal: Journal of Gastric Cancer

    Article Title: Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

    doi: 10.5230/jgc.2024.24.e25

    Figure Lengend Snippet: Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; CCK-8 = Cell Counting Kit-8; BrdU = Bromodeoxyuridine. Statistical significance was assessed by t-test; * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001.

    Article Snippet: The chemical inhibitors used were Galectin-1/LGALS1 (HY-P73072; MedChemExpress, Monmouth Junction, NJ, USA), EG00229 (HY-10799; MedChemExpress), and cisplatin (HY-17394; MedChemExpress).

    Techniques: CCK-8 Assay, Cell Counting

    Data are presented as the means ± standard error of the mean. Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; KEGG = Kyoto Encyclopedia of Genes and Genomes; GO = Gene Ontology; DEGs = differentially expressed genes; TCGA = The Cancer Genome Atlas; GEPIA = Gene Expression Profiling Interactive Analysis. * P<0.05, ** P< 0.01, *** P<0.005, **** P<0.001.

    Journal: Journal of Gastric Cancer

    Article Title: Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

    doi: 10.5230/jgc.2024.24.e25

    Figure Lengend Snippet: Data are presented as the means ± standard error of the mean. Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; KEGG = Kyoto Encyclopedia of Genes and Genomes; GO = Gene Ontology; DEGs = differentially expressed genes; TCGA = The Cancer Genome Atlas; GEPIA = Gene Expression Profiling Interactive Analysis. * P<0.05, ** P< 0.01, *** P<0.005, **** P<0.001.

    Article Snippet: The chemical inhibitors used were Galectin-1/LGALS1 (HY-P73072; MedChemExpress, Monmouth Junction, NJ, USA), EG00229 (HY-10799; MedChemExpress), and cisplatin (HY-17394; MedChemExpress).

    Techniques: Expressing

    Gal-1 = galectin-1; NRP-1 = neuropilin-1; GC = gastric cancer.

    Journal: Journal of Gastric Cancer

    Article Title: Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

    doi: 10.5230/jgc.2024.24.e25

    Figure Lengend Snippet: Gal-1 = galectin-1; NRP-1 = neuropilin-1; GC = gastric cancer.

    Article Snippet: The chemical inhibitors used were Galectin-1/LGALS1 (HY-P73072; MedChemExpress, Monmouth Junction, NJ, USA), EG00229 (HY-10799; MedChemExpress), and cisplatin (HY-17394; MedChemExpress).

    Techniques:

    Data are presented as the means ± standard error of the mean. Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; IC50 = half maximal inhibitory concentration; BrdU = Bromodeoxyuridine. * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001.

    Journal: Journal of Gastric Cancer

    Article Title: Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

    doi: 10.5230/jgc.2024.24.e25

    Figure Lengend Snippet: Data are presented as the means ± standard error of the mean. Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1; IC50 = half maximal inhibitory concentration; BrdU = Bromodeoxyuridine. * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001.

    Article Snippet: The chemical inhibitors used were Galectin-1/LGALS1 (HY-P73072; MedChemExpress, Monmouth Junction, NJ, USA), EG00229 (HY-10799; MedChemExpress), and cisplatin (HY-17394; MedChemExpress).

    Techniques: Concentration Assay

    Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1.

    Journal: Journal of Gastric Cancer

    Article Title: Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

    doi: 10.5230/jgc.2024.24.e25

    Figure Lengend Snippet: Gal-1 = galectin-1; GC = gastric cancer; NRP-1 = neuropilin-1.

    Article Snippet: The chemical inhibitors used were Galectin-1/LGALS1 (HY-P73072; MedChemExpress, Monmouth Junction, NJ, USA), EG00229 (HY-10799; MedChemExpress), and cisplatin (HY-17394; MedChemExpress).

    Techniques:

    Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Galectin-7 levels in relation to age.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Galectin-7 levels in relation to age.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques: